US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy
-
Drug News
US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy
iOnctura, a prominent clinical-stage biotechnology company dedicated to advancing revolutionary cancer therapies, has achieved a significant milestone with the recent…
Read More »
